logo
  

AstraZeneca Says Its Antibody Combination Treatment For Covid 'Evusheld' Approved In EU

AstraZeneca PLC (AZN.L) on Tuesday said its long-acting antibody combination treatment for Covid-19, Evusheld has ben approved in the European Union for individuals aged 12 years and more.

The approval was based on results from the TACKLE Phase 3 study of Evusheld, a combination of tixagevimab and cilgavimab. Results from the study showed that one dose of Evusheld provided clinically and statistically significant protection against progression to severe COVID-19 or death in non-hospitalised adults with mild-to-moderate COVID-19 who were symptomatic for seven days or less, compared to placebo.

Meanwhile, Evusheld was granted marketing authorisation in the EU for pre-exposure prophylaxis of COVID-19 in adults and adolescents earlier this year, and is already available in majority of countries in Europe.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Salt Lake City, Utah-based Rocky Mountain Pies, LLC is recalling Red Button Vintage Creamery French Silk Pie citing possible presence of undeclared almonds, a known allergen, the U.S. Food and Drug Administration said. The recall involves 31.88 oz French Silk Pie with the lot code beginning with 2 266. Only UPC code 0 41172 81290 9 is involved in the recall. The U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS has issued a public health alert against Paradise Locker Meats' certain fully cooked summer sausage products. There are concerns that the products may be contaminated with extraneous materials, specifically plastic. A recall was not requested as the products are no longer available for purchase. Hormel Foods Corp. (HRL) said, in the fourth quarter, the company delivered earnings per share comparable with record results last year, which included an additional week of sales. Pretax earnings were $357 million, up 1% from a year ago. Organic net sales were up 2%, excluding the impact of an additional...
Follow RTT